全文获取类型
收费全文 | 1441篇 |
免费 | 127篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 85篇 |
妇产科学 | 40篇 |
基础医学 | 138篇 |
口腔科学 | 64篇 |
临床医学 | 196篇 |
内科学 | 314篇 |
皮肤病学 | 34篇 |
神经病学 | 77篇 |
特种医学 | 159篇 |
外科学 | 111篇 |
综合类 | 28篇 |
预防医学 | 138篇 |
眼科学 | 16篇 |
药学 | 114篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 81篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 14篇 |
2020年 | 14篇 |
2019年 | 10篇 |
2018年 | 36篇 |
2017年 | 35篇 |
2016年 | 34篇 |
2015年 | 34篇 |
2014年 | 52篇 |
2013年 | 66篇 |
2012年 | 54篇 |
2011年 | 57篇 |
2010年 | 55篇 |
2009年 | 81篇 |
2008年 | 51篇 |
2007年 | 70篇 |
2006年 | 50篇 |
2005年 | 53篇 |
2004年 | 30篇 |
2003年 | 31篇 |
2002年 | 26篇 |
2001年 | 35篇 |
2000年 | 27篇 |
1999年 | 38篇 |
1998年 | 72篇 |
1997年 | 86篇 |
1996年 | 58篇 |
1995年 | 52篇 |
1994年 | 38篇 |
1993年 | 44篇 |
1992年 | 21篇 |
1991年 | 16篇 |
1990年 | 18篇 |
1989年 | 34篇 |
1988年 | 24篇 |
1987年 | 30篇 |
1986年 | 24篇 |
1985年 | 27篇 |
1984年 | 13篇 |
1983年 | 19篇 |
1982年 | 11篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1975年 | 3篇 |
1972年 | 3篇 |
排序方式: 共有1614条查询结果,搜索用时 15 毫秒
41.
42.
Ted A. Skolarus MD MPH Andrew M.D. Wolf MD Nicole L. Erb BA Durado D. Brooks MD MPH Brian M. Rivers PhD MPH Willie Underwood III MD MPH MSci Andrew L. Salner MD Michael J. Zelefsky MD Jeanny B. Aragon‐Ching MD Susan F. Slovin MD PhD Daniela A. Wittmann PhD MSW CST Michael A. Hoyt PhD Victoria J. Sinibaldi CRNP Gerald Chodak MD Mandi L. Pratt‐Chapman MA Rebecca L. Cowens‐Alvarado MPH 《CA: a cancer journal for clinicians》2014,64(4):225-249
Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow‐up care to address the myriad of long‐term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow‐up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow‐up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long‐term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility‐specific and population databases. CA Cancer J Clin 2014;64:225–249. © 2014 American Cancer Society . 相似文献
43.
The practice of fasting recently has been purported to have clinical benefits, particularly as an intervention against obesity and its related pathologies. Although a number of different temporal dietary restriction strategies have been employed in practice, they are generally classified under the umbrella term “intermittent fasting” (IF). IF can be stratified into two main categories: (1) intra-weekly fasting (alternate-day fasting/ADF, twice-weekly fasting/TWF) and (2) intra-daily fasting (early time-restricted eating/eTRE and delayed time-restricted eating/dTRE). A growing body of evidence indicates that IF is a viable alternative to daily caloric restriction (DCR), showing effectiveness as a weight loss intervention. This paper narratively reviews the literature on the effects of various commonly used IF strategies on body weight and body composition when compared to traditional DCR approaches, and draws conclusions for their practical application. A specific focus is provided as to the use of IF in combination with regimented exercise programs and the associated effects on fat mass and lean mass. 相似文献
44.
氯地滴眼液的含量测定 总被引:4,自引:0,他引:4
目的:采用HPLC法测定氯地滴眼液中氯霉素和地塞米松磷酸钠的含量。方法:色谱分析条件:ODS柱作分析柱,流动相为甲醇/水体系,0 ̄8min使用40%甲醇,8 ̄16min使用60%甲醇,流速1ml/min,0 ̄9min240nm紫外检测,:二组分分离良好。各组各组性关系良好,平均回收率氯霉素99.8%(RSD=1.2%,n=5),地塞米松磷酸钠99.4%(RSD=0.7%,n=5),结论:该法用于氯 相似文献
45.
Singapore Indian Eye Study‐2: methodology and impact of migration on systemic and eye outcomes
下载免费PDF全文
![点击此处可从《Clinical & experimental ophthalmology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
46.
范春明 《中国组织工程研究与临床康复》2007,11(24):4806-4809
目的:分析胚胎干细胞和胚胎生殖细胞的生物学特性、体外培养条件、周围微环境对其增殖分化的影响,了解胚胎干细胞和胚胎生殖细胞的关系和应用前景。方法:应用计算机检索万方数据库2000/2007有关生殖细胞、胚胎干细胞、胚胎生殖细胞的相关研究文章,检索词:生殖细胞,胚胎干细胞,胚胎生殖细胞,并限定文章语言种类为中文;同时应用计算机检索PUBMED2000/2006相关文章,检索词:Germ Cells,Primordial germ cells,Embryonic stem cells,Embryonic Germ Cells,限定文章语言种类为“English”。对资料进行初审,纳入标准为有关生殖细胞、胚胎干细胞、胚胎生殖细胞的生物学特性、体外培养及生长抑制因子的作用等相关文章,并查找全文。主要选择基础研究类文章,无论有无对照组均纳入。结果:共检索到相关文章59篇,排除比较陈旧的文章,最后纳入38篇进行总结分析。胚胎干细胞与胚胎生殖细胞分别从附置前早期胚胎内细胞团和早期胎儿生殖嵴原始生殖细胞分离克隆出来,均具有自我更新、无限增殖能力及多向分化潜能,在体外培养条件下可保持稳定的二倍体核型,诱导分化后可形成3种胚胎生殖层。饲养层细胞是人胚胎生殖细胞体外培养的必要条件,常用饲养层细胞有鼠STO细胞系、鼠胚胎成纤维细胞,体外生长所需主要细胞因子包括干细胞生长因子、碱性成纤维细胞生长因子和白血病抑制因子,然而只要在培养基中加入鼠成纤维细胞的上清液和碱性成纤维细胞生长因子,胚胎干细胞可在无饲养层的条件下进行体外培养。结论:胚胎干细胞和胚胎生殖细胞具有相似的增殖特性,一定条件下可以分化为包括生殖细胞在内的所有功能细胞,并可相互转变,在胚胎发育、基因治疗、药物筛选、新药开发、生殖医学及人类疾病的移植治疗中具有广泛的应用前景。 相似文献
47.
48.
49.
50.